Supporting Evidence

1535 bookmarks
Newest
Dr. Jessica Rose: VAERS: Key Ways to Prove C19 Jab Harm Causation
Dr. Jessica Rose: VAERS: Key Ways to Prove C19 Jab Harm Causation
How are jab adverse events proved? The inaugural Understanding Vaccine Causation Conference brought together legal practitioners, doctors, scientists, advocacy groups, and more to discuss this key question.
·worldcouncilforhealth.org·
Dr. Jessica Rose: VAERS: Key Ways to Prove C19 Jab Harm Causation
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site
Among numerous point mutation differences between the SARS-CoV-2 and the bat RaTG13 coronavirus, only the 12-nucleotide furin cleavage site (FCS) exceeds 3 nucleotides. A BLAST search revealed that a 19 nucleotide portion of the SARS-CoV-2 genome encompassing the furin cleavage site is a 100% complementary match to a codon-optimized proprietary sequence that is the reverse complement of the human mutS homolog (MSH3). The reverse complement sequence present in SARS-CoV-2 may occur randomly but other possibilities must be considered. Recombination in an intermediate host is an unlikely explanation. Single stranded RNA viruses such as SARS-CoV-2 utilize negative strand RNA templates in infected cells, which might lead through copy choice recombination with a negative sense SARS-CoV-2 RNA to the integration of the MSH3 negative strand, including the FCS, into the viral genome. In any case, the presence of the 19-nucleotide long RNA sequence including the FCS with 100% identity to the reverse complement of the MSH3 mRNA is highly unusual and requires further investigations.
·frontiersin.org·
MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site
Physician: ‘Fanaticism’ — Not Science — Governs CDC’s Aggressive Push to Vaccinate Even Those With Natural Immunity
Physician: ‘Fanaticism’ — Not Science — Governs CDC’s Aggressive Push to Vaccinate Even Those With Natural Immunity
Public health insiders increasingly are calling out the U.S. Centers for Disease Control and Prevention over the “insanity” of pushing COVID vaccines on people who have already acquired natural immunity.
·childrenshealthdefense.org·
Physician: ‘Fanaticism’ — Not Science — Governs CDC’s Aggressive Push to Vaccinate Even Those With Natural Immunity
Look into UK Yellow Card System Reveals Large Numbers of Adverse Events & Deaths Associated with COVID-19 Vaccine
Look into UK Yellow Card System Reveals Large Numbers of Adverse Events & Deaths Associated with COVID-19 Vaccine
In the United Kingdom, the COVID-19 vaccines were administered starting on December 8, 2020, and by May 6th, almost 39 million people there had received their first dose of the COVID-19 vaccine, with 24 million people receiving two doses, hence completely vaccinated. Given this data accumulation sufficient information was available for a review of the UK’s Yellow Card -based safety and adverse event reporting system. Recently, the Director of the Evidence-based Medicine Consultancy, Ltd and EbMC Squared CiC , Dr. Tess Lawrie wrote to the UK Medicines and Healthcare Products Regulatory Agency (MHRA) with concerns about what appear to be accumulating adverse event data. For example, Dr. Lawrie raises the awareness that just between January 4, 2021 and May 26, 2021 a total of 1,253 deaths and 888,196 adverse events were reported, which aren’t directly proven as correlated with the vaccine process but most certainly could be so. So this means that in the real world about 4.5% of those that receive the vaccine could possibly have had an adverse event if these incidents are correlated to the jab. But that’s not proven here. Nonetheless, Lawrie has mounting concerns for people in the UK.
·trialsitenews.com·
Look into UK Yellow Card System Reveals Large Numbers of Adverse Events & Deaths Associated with COVID-19 Vaccine
Chairman of the Tokyo Medical Association: Household Doctors Should Prescribe Ivermectin to Treat COVID-19
Chairman of the Tokyo Medical Association: Household Doctors Should Prescribe Ivermectin to Treat COVID-19
On February 9th a prominent member of the medical establishment here came out in a very public manner in favor of ivermectin as a treatment for not only patients infected with SARS-CoV-2, the virus behind COVID-19, but also their caregivers. Reported in The Nikkei, a prominent Japanese economics and business focused publication, Haruo Ozaki, chairman of the Tokyo Medical Association, came out and recommended the emergency use of drugs such as Ivermectin administered to those COVID-19 patients, declaring they exhibit efficacy toward preventing disease progression in other nations. Clearly, Dr. Ozaki falls on the side of a rapidly growing group of physicians and researchers that align with significant meta-analyses involving dozens of randomized controlled trials, observational studies and case series around the world. Ozaki also calls out for Japan health authorities to use dexamethasone shown to help lower the death rate in certain more severe situations in hospitalized patients.
·trialsitenews.com·
Chairman of the Tokyo Medical Association: Household Doctors Should Prescribe Ivermectin to Treat COVID-19
Gilead Sciences Sets US Price for COVID-19 Drug at $2340 to $3120 Based on Insurance
Gilead Sciences Sets US Price for COVID-19 Drug at $2340 to $3120 Based on Insurance
In the United States, Gilead Sciences set the price for remdesivir, its antiviral drug that can shorten hospitalization stays for individuals ill with coronavirus disease 2019 (COVID-19), based on insurance factors, and is allowing generic drug makers to create the drug for less in low to middle income countries.
·ajmc.com·
Gilead Sciences Sets US Price for COVID-19 Drug at $2340 to $3120 Based on Insurance
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19
After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents ...
·ncbi.nlm.nih.gov·
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19